Cellectis SA (CLLS)
4.84
+0.06
(+1.26%)
USD |
NASDAQ |
Dec 31, 16:00
4.86
+0.02
(+0.41%)
After-Hours: 20:00
Cellectis Free Cash Flow: -34.73M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EDAP TMS SA | -- |
| DBV Technologies SA | -98.65M |
| Genfit SA | -7.599M |
| Ascendis Pharma A/S | -123.89M |
| Akari Therapeutics Plc | -9.678M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.627M |
| Cash from Investing (Quarterly) | -3.266M |
| Cash from Financing (Quarterly) | -4.089M |
| Free Cash Flow Per Share (Quarterly) | -0.0391 |
| Free Cash Flow to Equity (Quarterly) | -9.372M |
| Free Cash Flow to Firm (Quarterly) | -4.857M |
| Free Cash Flow Yield | -7.67% |